Skip to main content
. 2019 May 15;10:1015. doi: 10.3389/fimmu.2019.01015

Figure 6.

Figure 6

Mix multi-target VLP-based vaccine increased CD8+ T-cell infiltration into B16F10 tumor and enhanced the survival. (A) Density of CD8+ T-cells (means ± SEM) in tumor, pre-gated on TILs in the groups vaccinated with Qβ(CpGs)-VLPs, anti-CD25, GL-MTV, Mutated-MTV, and Mix-MTV. The density measured by dividing the total number of CD8+ T-cells in each tumor by its volume. (B) Density of CD8+ IFN-γ+ secreting cells (means ± SEM) in tumor, pre-gated on TILs in the vaccinated groups. Statistical analysis by one-way ANOVA. (C) Representative FACS plots showing the total number of CD8+ T-cells in each tumor in the vaccinated groups. (D) Survival of mice in the vaccinated groups, mice were euthanized when the tumor reached 1,000 mm3. The arrows indicate vaccination time. Statistical analysis by log-rank test. The groups of GL-MTV, Mutated-MTV, and Mix-MTL were combined with anti-CD25mAb in all experiments. (n = 5) mice per group, one representative of 3 similar experiments is shown. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.